Solution
POCT
Household product series
Pet product series
Immunohistochemistry—anti-test reagent A-G series
Immunohistochemistry primary antibody test reagent
NEWS

Conference Review: Qi's from Shenzhen was invited to attend the 2022 Third Shenzhen Non-public Medical Association Laboratory Branch Academic Exchange Annual Conference.

    On November 29th, the Third Annual Conference on New Technologies and Progress in Laboratory Medicine, co-hosted by the Shenzhen Non-public Medical Industry Association Laboratory Branch, was successfully held in Longhua District, Shenzhen. The meeting invited well-known experts from the province and city to conduct academic exchanges on the content of new technologies and progress in laboratory medicine. Association units and more than 50 laboratory experts conducted online and offline synchronized teaching. Qi's was honored to be a guest at this conference.


1700581656344409.png


    The participants mainly included nearly 50 industry experts such as Mr. Feng Chunyan, President of the Shenzhen Non-public Medical Association Laboratory Branch, Ms. Zhang Yan, President of Shenzhen Renhe Hospital, Mr. Zhao Xiangsheng, former Chairman of the Shenzhen Medical Association Laboratory Special Committee, Ms. Liu Xiaoping, Director of the Laboratory Medicine Department of Peking University Shenzhen Hospital, Mr. Wang Feng, Director of the Laboratory Department of Bao'an District Maternal and Child Health Hospital of Shenzhen, Mr. Cao Ke, Director of the Laboratory of Shenzhen Children's Hospital, and Mr. Zhang Guanghui, Director of the Laboratory of Shenzhen Hengsheng Hospital.


会议回顾2.png


    At the beginning of the meeting, Mr. Feng Chunyan, President of the Shenzhen Non-public Medical Association Laboratory Branch, delivered the opening speech, expressing his heartfelt gratitude to all the vice presidents, members, and guests for their contributions to Shenzhen non-public medical testing in the past. He hoped that everyone would work together in the future to build the Shenzhen Non-public Medical Association Laboratory Branch better and also gave a speech on the topic of post-pandemic times. The expert lectures were synchronized online and offline.

    Ms. Liu Xiaoping, Director of the Laboratory Medicine Department of Peking University Shenzhen Hospital, presented a topic on "Clinical Application of New Technologies for Cervical Cancer Screening".



会议回顾3.png


    Mr. Zhang Guanghui, Vice President of the Shenzhen Non-public Medical Association Laboratory Branch and Director of the Laboratory of Shenzhen Hengsheng Hospital, shared a special course on "Screening and Quality Control for High-risk Populations with Diabetes".


会议回顾4.png


    Mr. Lian Zhengxin, the founder of Qi's, gave a wonderful speech on "Development of Precision Medical Products and Professional Medical Service Institutions Based on Molecular Biology" at the conference. He also shared the challenges and opportunities we face in the post-pandemic era. In the future, Qi's will use its professional technical services to work with the colleagues in Shenzhen Non-public Medical Laboratory Branch to grow and progress together. He said Qi's would contribute its part to improving non-public medical services in Shenzhen.

会议回顾5.png


    During the conference, Qi's displayed a variety of products based on the company's full product line, mainly including fully automated pathological diagnosis systems, POC testing systems, COVID-19 testing projects, third-party medical inspection laboratories, and multiple technological platforms. Qi's has also established a professional medical service institution based on molecular biology for precision medicine product research and development. The company relies on biotechnology innovation centers and medical laboratory centers to create two major R&D technical platforms for in vitro diagnostic reagents and automated diagnostic instruments. The company's comprehensive solution can help departments quickly carry out different inspection and pathological field projects, with the characteristics of fully automated integration, convenience and rapidness, increased departmental efficiency, and project diversity. In the future, we will continue to innovate continuously and work hard to accumulate strength for the development of innovative medical device and reagent.


seo seo